New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic

G. Rayman (Lead / Corresponding author), A. Lumb, B. Kennon, C. Cottrell, D. Nagi, E. Page, D. Voigt, H. Courtney, H Atkins, J. Platts, K. Higgins, K. Dhatariya, M. Patel, P. Narendran, P. Kar, P. Newland-Jones, O. Burr, R. Stewart, S. Thomas

Research output: Contribution to journalLetterpeer-review

14 Citations (Scopus)
74 Downloads (Pure)


The COVID-19 pandemic has had a dramatic impact on the provision of acute inpatient care with specialists from all disciplines having to manage patients outside of their usual speciality areas. In many UK hospitals diabetes consultants and diabetes inpatient specialist nurses have been redeployed to the wards to care for COVID-19 positive or suspected cases. Consequently, clinicians relatively unfamiliar with managing hyperglycaemia have been required to do so as the usual input from diabetes specialist teams has not been possible in many areas.

Original languageEnglish
Pages (from-to)1210-1213
Number of pages4
JournalDiabetic Medicine
Issue number7
Early online date17 May 2020
Publication statusPublished - 18 Jun 2020

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic'. Together they form a unique fingerprint.

Cite this